Data shows bad reactions to Ozempic and Wegovy spike

Taking Ozempic or Wegovy could make you hate meat, new research shows

For many people, Ozempic is a game-changer in the fight against obesity. But while the drug is known for its powerful appetite-suppressing effects, some users are reporting dramatic shifts in how food tastes. These Ozempic-driven taste changes can include strong aversions to meat, fried foods, and even formerly favorite dishes—turning once-loved meals into culinary turn-offs. Alyssa Fraser, a former food journalist, told Scientific American that…

Data shows bad reactions to Ozempic and Wegovy spike

The findings come after reports of nasty side effects - including eye problems, infections and gastrointestinal disorders - nearly tripled from 2022 to 2023.

Mounjaro vs. Wegovy: New Trial Reveals the More Effective Weight-Loss Drug

The battle of the most powerful weight-loss drugs available. Credit: Marco Verch, cc2/Flickr The first head-to-head trial of Mounjaro and Wegovy, the weight-loss drugs, funded by Eli Lilly, the maker of Mounjaro, has compared the effectiveness of the two leading drugs in a group of 750 obese participants. With an average starting weight of 113kg (nearly 18 stone), participants were assigned the highest tolerable dose of either Mounjaro or Wegovy…

The body positive is dead and I don’t know if there is enough feminism to contain the desire to lose weight without meriting it and look like those that look like Instagram filters, at any price. La entrada Now I want to click Ozempic was first published in Pikara Magazine.

That Ozempic Headache Is Real — Here’s How To Beat It

Headaches are a common and frustrating side effect some people experience while taking the popular weight loss drug Ozempic, but the medication itself may not be to blame. According to fitness and nutrition expert Dr. Chris Mohr and board-certified physician Dr. Raj Dasgupta, these headaches are typically a result of how the drug interacts with your body, not a direct effect of the medication. Source: Daniel de la Hoz During an interview with Wo…

A description that fits precisely into the current situation of drugs such as the popular Ozempic, whose supply has been strained for years without the emergence of new alternatives — such as Wegovy or Mounjaro — having managed to solve the problem. All these drugs belong to the group of GLP-1 agonists, originally developed and approved for the treatment of type 2 diabetes. However, in recent years they have gained enormous notoriety because of …